Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary tuberculosis.

C S Hirsch1, J L Johnson, J J Ellner

  • 1Case Western Reserve University, Department of Medicine, Cleveland, OH 44106-4984, USA.

Current Opinion in Pulmonary Medicine
|May 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of premorbid nutritional status on TB severity.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

One step further: improving paediatric TB diagnosis through user-centred research approaches.

IJTLD open·2024
Same author

Sex and age differences in Mycobacterium tuberculosis infection in Brazil.

Epidemiology and infection·2018
Same author

Adverse medical complications: an under-reported contributory cause of death in New York City.

Public health·2014
Same author

Inhibition of Mycobacterium tuberculosis-induced signalling by transforming growth factor-β in human mononuclear phagocytes.

Scandinavian journal of immunology·2011
Same author

Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation.

Clinical and experimental immunology·2011
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Tuberculosis (TB) remains a leading infectious cause of death globally, exacerbated by HIV co-infections. Global efforts focus on improved diagnostics, vaccines, preventive therapy, and new treatments like rifapentine to combat this disease.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Microbiology

Background:

  • Pulmonary tuberculosis (TB) is a significant global health burden, causing widespread morbidity and mortality.
  • The increasing prevalence of HIV co-infection with Mycobacterium tuberculosis (MTB) complicates TB control efforts.
  • Urgent global strategies are needed to address the persistent threat of TB.

Purpose of the Study:

  • To review recent advancements in TB diagnostics and vaccine development.
  • To highlight strategies for managing HIV-MTB co-infections, including preventive therapy.
  • To discuss novel therapeutic agents and treatment regimens for TB.

Main Methods:

  • Literature review of recent developments in TB research and control.
  • Synopsis of ongoing clinical trials for new antitubercular agents.

Related Experiment Videos

  • Analysis of global health organization initiatives for TB management.

    • Main Results:

    • Advancements in TB diagnostics and vaccine development are crucial for control.
    • Preventive therapy is vital for individuals with HIV-MTB co-infection.
    • Newer, longer-acting drugs like rifapentine offer improved dosing regimens.

    Conclusions:

    • Global collaboration is essential for effective TB control.
    • Continued research into diagnostics, vaccines, and therapeutics is necessary.
    • Implementing updated treatment strategies can reduce TB-related mortality.